DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

21 Drugs in Development

21 Drugs in Development

DIGITAL CONTENT

15 NEWS #PharmaBuzz

media
15 NEWS #PharmaBuzz

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

21DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Ory-1001 free base, Iadademstat [inn], 1431304-21-0, Chembl3781751, 1431304-21-0 (free base), 54t74394f8

Molecular Formula

C₁₅H₂₂N₂

Molecular Weight

230.35 g/mol

InChI Key

ALHBJBCQLJZYON-PFSRBDOWSA-N

FDA UNII

54T74394F8

Iadademstat is an orally available inhibitor of lysine specific histone demethylase 1 (KDM1A; LSD1), with potential antineoplastic activity. Upon administration, iadademstat binds to and inhibits LSD1, a demethylase that suppresses the expression of target genes by converting the di- and mono-methylated forms of lysine at position 4 of histone H3 (H3K4) to mono- and unmethylated H3K4, respectively. LSD1 inhibition enhances H3K4 methylation and increases the expression of tumor suppressor genes. This may lead to an inhibition of cell growth in LSD1-overexpressing tumor cells. In addition, LSD1 demethylates mono- or di-methylated H3K9, which increases gene expression of tumor promoting genes; inhibition of LSD1 promotes H3K9 methylation and decreases transcription of these genes. LSD1, an enzyme belonging to the flavin adenine dinucleotide (FAD)-dependent amine oxidase family, is overexpressed in certain tumor cells and plays a key role in in the regulation of gene expression, tumor cell growth and survival.

1 2D Structure

Iadademstat

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

4-N-[(1R,2S)-2-phenylcyclopropyl]cyclohexane-1,4-diamine

2.1.2 InChI

InChI=1S/C15H22N2/c16-12-6-8-13(9-7-12)17-15-10-14(15)11-4-2-1-3-5-11/h1-5,12-15,17H,6-10,16H2/t12?,13?,14-,15+/m0/s1

2.1.3 InChI Key

ALHBJBCQLJZYON-PFSRBDOWSA-N

2.1.4 Canonical SMILES

C1CC(CCC1N)NC2CC2C3=CC=CC=C3

2.1.5 Isomeric SMILES

C1CC(CCC1N)N[C@@H]2C[C@H]2C3=CC=CC=C3

2.2 Other Identifiers

2.2.1 UNII

54T74394F8

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. Ory-1001 Free Base

2. Iadademstat [inn]

3. 1431304-21-0

4. Chembl3781751

5. 1431304-21-0 (free Base)

6. 54t74394f8

7. Rg-6016

8. N-[(1r,2s)-2-phenylcyclopropyl]-1,4-cyclohexanediamine

9. 4-n-[(1r,2s)-2-phenylcyclopropyl]cyclohexane-1,4-diamine

10. Trans-n1-((1r,2s)-2-phenylcyclopropyl)-1,4-cyclohexanediamine

11. Trans-n1-((1r,2s)-2-phenylcyclopropyl)cyclohexane-1,4-diamine

12. 1,4-cyclohexanediamine, N1-((1r,2s)-2-phenylcyclopropyl)-, Trans-

13. Ory1001

14. Starbld0049467

15. Iadademstat [who-dd]

16. Gtpl8390

17. Chembl3906257

18. Chembl5028924

19. Schembl14880401

20. Schembl14880402

21. Schembl14880654

22. Bdbm254603

23. Unii-54t74394f8

24. Bdbm50155773

25. Nsc806812

26. Rg6016

27. Zinc94088493

28. Nsc-806812

29. Ncgc00480828-02

30. Ncgc00480828-04

31. Us9469597, 4

2.4 Create Date

2013-06-11

3 Chemical and Physical Properties

Molecular Formula	C₁₅H₂₂N₂
Molecular Weight	230.35 g/mol
XLogP3	2.1
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	2
Rotatable Bond Count	3
Exact Mass	230.178298710 g/mol
Monoisotopic Mass	230.178298710 g/mol
Topological Polar Surface Area	38 Å²
Heavy Atom Count	17
Formal Charge	0
Complexity	239
Isotope Atom Count	0
Defined Atom Stereocenter Count	2
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1